HeartStart MRx various Models End of Delivery and Support Notification May 2017.pdf
10 May 2017
Philips HeartStart MRx Monitor/Defibrillator Global Discontinuance Communication
Dear Philips Valued HeartStart MRx Customer,
We appreciate your loyalty as a customer of our Philips HeartStart products to help you care for your
patients. Please be advised that Philips has made the decision to discontinue the HeartStart MRx
monitor/defibrillator, one of our Advanced Life Support products, which has reached the end of its
Production and sale of new HeartStart MRx monitor/defibrillators is discontinued effective May 10, 2017.
Philips will support our valued HeartStart MRx customers through December 31, 2022, and will ensure the
availability of service parts, accessories and consumables during this period. This support includes
extended warranty and service options, which may be available for your existing MRx devices.
HeartStart MRx Models:
M3535A, M3536A, M3536M, MC, M3, M6, M7, M8, M9
End of Sales/Delivery
May 10, 2017
End of Support
December 31, 2022
The Philips HeartStart MRx monitor/defibrillator has had a long and successful history in helping save the
lives of Sudden Cardiac Arrest (SCA) victims and helping care for patients in emergencies worldwide. With
nearly 100,000 units produced and shipped around the globe since its launch, the HeartStart MRx has
been a key component of the life-saving continuum for first responders and medical professionals.
Philips remains strongly committed to the future of our Emergency Care & Resuscitation business. Our
other HeartStart product lines remain available, such as the HeartStart XL+ and DFM 100
monitor/defibrillators (outside the U.S.), and the FR3, FRx, Home and Onsite AED5 (global).
We continue to invest heavily in R&D, including the ongoing development of next-generation Advanced
Life Support Monitor/Defibrillators and AED5 with expanded features such as advanced connectivity and
transformative technology for helping save lives. We will inform you as soon as possible about the
availability of the successor to the HeartStart MRx, which is currently in development. We also recently
launched a significant upgrade to the Efficia DFM 100 and are currently working on new features to further
enhance the HeartStart XL+. We continue our commitment to comply with the Pre-Market Approval
process mandated by the U.S. FDA for defibrillators with an AED mode.
Further information is available from your Philips representative. Thank you for choosing Philips
Emergency Care and Resuscitation
3000 Minuteman Road Andover MA 01810 USA